Paladin Labs Inc. the Montreal-based pharmaceutical company that earlier this week announced the take-over of drug-maker Labopharm Inc. , said Thursday that its president and chief executive officer Jonathan Goodman is in hospital with serious injuries after an accident.
The company did not reveal what kind of accident was involved, but the injuries are serious, and are still being assessed, it said.
Paladin’s board has appointed Mark Beaudet, a co-founder of the company and currently vice-president of sales, to take Mr. Goodman’s place as CEO for the time being.
As well as the bid for Labopharm, Paladin also recent proposed a takeover of Afexa Life Sciences Inc., the Edmonton company that makes COLD-FX.
In a statement Mr. Beaudet said the management team will continue to advance all of the company’s on-going projects.
Mr. Goodman founded Paladin in 1996. It now distributes dozens of pharmaceutical products in Canada and other countries, ranging from prostate cancer treatments to birth control pills to wart medications.